Carlsmed, Inc. (CARL)
NMS · Healthcare · Health Information Services
$11.42
-1.72%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$310.5M
Shares Outstanding
27.2M
P/S (TTM)
5.5x
Exchange
NMS
Currency
USD
About Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 12.1M | 13.1M | 15.2M | 16.1M |
| Gross Profit | 8.9M | 9.9M | 11.6M | 12.4M |
| Operating Income | -6.5M | -9.0M | -9.3M | -9.3M |
| Net Income | -6.8M | -8.5M | -8.6M | -8.7M |
| Diluted EPS | $-1.47 | $-0.40 | $-0.32 | $-0.32 |
Annual Financials
| Metric | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Revenue | 13.8M | 27.2M | 50.5M |
| Gross Profit | 9.9M | 20.0M | 38.0M |
| Operating Income | -18.6M | -24.1M | -30.6M |
| Net Income | -18.9M | -24.3M | -29.6M |
| Diluted EPS | $-4.25 | $-6.11 | $-2.12 |